Dergiler / Turkish Journal of Pharmaceutical Sciences / 2022 / Cilt: 19 - Sayı: 2

Ameliorative Effect of Marine Macroalgae on Carbon Tetrachloride-Induced Hepatic Fibrosis and Associated Complications in Rats

Sayfa
116–124
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: WE of C. racemosa has shown great potential in attenuating liver fibrosis induced by CCl4.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: Liver fibrosis is one of the serious health concern around the globe.
📊
Temel Bulgular & Veri:This study was conducted to evaluate the protective role of two seaweeds Padina pavonia and Caulerpa racemosa in carbon tetrachloride (CCl4)-induced liver fibrosis in rats.
💡
Sonuç & Katkı:Conclusion: WE of C. racemosa has shown great potential in attenuating liver fibrosis induced by CCl4.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: Liver fibrosis is one of the serious health concern around the globe. Persistent exposure to drugs, toxicants, and pathogens may induce liver fibrosis. Marine macroalgae are globally consumed because of nutritive and medicinal value. This study was conducted to evaluate the protective role of two seaweeds Padina pavonia and Caulerpa racemosa in carbon tetrachloride (CCl4)-induced liver fibrosis in rats. Materials and Methods: Animal model of hepatic fibrosis was developed by injecting 40% CCl4 dissolved in olive oil [2 mL/kg, body weight (b.w.), i.p.] on alternate days for 30 days. Water extracts (WE) [200 mg/kg b.w., p.o.] of P. pavonia and C. racemosa were given to rats daily for 30 days. On day 31, rats were sacrificed after 12 h fasting. Serum was used for biochemical estimation. 10% neutral buffered formalin was used to preserve the liver sample for histopathological examination, while the other portion was used for the preparation of tissue homogenate to estimate antioxidant enzymes and malondialdehyde levels. Results: WEs of both marine macro-algae significantly abrogate the elevated serum concentrations of aminotransferases (alanine aminotransferase and aspartate aminotransferases), alkaline phosphatase and lactate dehydrogenase along with a substantial (p<0.05) reduction in serum bilirubin levels. They also showed positive effects on oxidative stress, evident by improvement in reduced glutathione, catalase, and glutathione peroxidase activities and down regulation of lipid peroxidation level, with stabilizing the destructive cellular morphology of liver induced by repeated CCl4 injection. Both algal extracts also improved kidney function (urea and creatinine) along with lipid metabolism (triglycerides and cholesterol). Conclusion: WE of C. racemosa has shown great potential in attenuating liver fibrosis induced by CCl4.

🔖

Bu Makaleye Atıf Yap

AZAM, M., HIRA, K., QURESHI, S. A., KHATOON, N., ARA, J., EHTESHAMUL-HAQUE, S. (2022). Ameliorative Effect of Marine Macroalgae on Carbon Tetrachloride-Induced Hepatic Fibrosis and Associated Complications in Rats. Turkish Journal of Pharmaceutical Sciences, Cilt: 19 - Sayı: 2, 116–124. https://ajindex.com/articles/408596

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Hira K, Sultana V, Ara J, Ehteshamul-Haque S. Protective role of Sargassum species in liver and kidney dysfunctions and associated disorders in rats intoxicated with carbon tetrachloride and acetaminophen. Pak J Pharm Sci. 2017;30:721-728
  2. Blaner WS, O’Byrne SM, Wongsiriroj N, Kluwe J, D’Ambrosio DM, Jiang H, Schwabe RF, Hillman EM, Piantedosi R, Libien J. Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage. Biochim Biophys Acta. 2009;1791:467-473
  3. Laskin DL, Sunil VR, Gardner CR, Laskin JD. Macrophages and tissue injury: agents of defense or destruction? Annu Rev Pharmacol Toxicol. 2011;51:267-288
  4. Baiocchini A, Montaldo C, Conigliaro A, Grimaldi A, Correani V, Mura F, Ciccosanti F, Rotiroti N, Brenna A, Montalbano M, D’Offizi G, Capobianchi MR, Alessandro R, Piacentini M, Schininà ME, Maras B, Del Nonno F, Tripodi M, Mancone C. Extracellular matrix molecular remodeling in human liver fibrosis evolution. PloS One. 2016;11:e0151736
  5. Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol. 2011;25:195-206
  6. Byass P. The global burden of liver disease: a challenge for methods and for public health. BMC Med. 2014;12:159
  7. Yoo S, Wang W, Wang Q, Fiel MI, Lee E, Hiotis SP, Zhu J. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low-and high-degree liver fibrosis. BMC Med. 2017;15:214
  8. Schiff ER, Maddrey WC, Sorrell MF. Schiff’s Diseases of the Liver. (11th ed). West Sussex: John Wiley & Sons; 2011
  9. Marcellin P, Gane E, Buti M, Afdhal N, Sievert W, Jacobson IM, Washington MK, Germanidis G, Flaherty JF, Aguilar Schall R, Bornstein JD, Kitrinos KM, Subramanian GM, McHutchison JG, Heathcote EJ. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet. 2013;381:468-475
  10. Dong S, Chen QL, Song YN, Sun Y, Wei B, Li XY, Hu YY, Liu P, Su SB. Mechanisms of CCl4-induced liver fibrosis with combined transcriptomic and proteomic analysis. J Toxicol Sci. 2016;41:561-572
  11. Halliwell B, Gutteridge JM. Free radicals in biology and medicine. (5th ed). New York, USA: Oxford University Press; 2015
  12. Klaas M, Kangur T, Viil J, Mäemets-Allas K, Minajeva A, Vadi K, Antsov M, Lapidus N, Järvekülg M, Jaks V. The alterations in the extracellular matrix composition guide the repair of damaged liver tissue. Sci Rep. 2016;6:27398.